- Home
- »
- Nutraceuticals & Functional Foods
- »
-
U.S. Probiotic Dietary Supplement Market Size Report, 2033GVR Report cover
U.S. Probiotic Dietary Supplement Market (2026 - 2033)
Size, Share & Trends Analysis Report By Form (Chewable & Gummies, Capsules, Powders, Tablets & Softgels, Others), By Application, By End Use, And Segment Forecasts
Market Size, 2025
$2.7BMarket Estimate, 2026
$2.8BMarket Forecast, 2033
$4.0BCAGR, 2026–2033
4.8%U.S. Probiotic Dietary Supplement Market Summary
The U.S. probiotic dietary supplement market size was valued at USD 2.7 billion in 2025 and is projected to grow from USD 2.8 billion in 2026 to USD 4.0 billion by 2033, at a CAGR of 4.8% from 2026 to 2033. The increasing awareness of gut health, fueled by rising digestive and immune health concerns, drives market growth.
Key Market Trends & Insights
- By form: Tablets & softgels segment held the largest market share of 38.0% in 2025.
- By application: Gastrointestinal health segment dominated the market with a revenue share of 64.2% in 2025.
- By end use: Adults segment held the largest revenue share of 55.7% in 2025.
Key Market Trends & Insights
- Market Size in 2025: USD 2.7 Billion
- Estimated Market Size in 2026: USD 2.8 Billion
- Projected Market Size by 2033: USD 4.0 Billion
- CAGR (2026-2033): 4.8%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
In addition, expanding e-commerce and the growing influence of health-focused social media have enhanced accessibility and consumer adoption, supporting market growth. Consumers in the U.S. have become more proactive about maintaining digestive balance and strengthening their body’s natural defenses, positioning probiotics as an essential part of daily wellness routines. Scientific validation further strengthens consumer confidence and drives demand in the U.S. probiotic dietary supplement market. The National Center for Complementary and Integrative Health (NCCIH) describes probiotics as live microorganisms that may provide health benefits when consumed in adequate amount. The agency highlights that probiotics show promise for certain uses, but also notes that more research is needed to determine which specific strains and dosages are most effective for particular populations and purpose. This balanced scientific perspective promotes transparency, motivating manufacturers to invest in clinical validation and encouraging consumers to choose products backed by credible research, thereby driving steady market expansion.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Product innovation continues to drive the U.S. market expansion, with companies introducing diverse probiotic supplement forms, such as capsules, gummies, powders, and chewables, to enhance convenience and compliance. Manufacturers develop formulations with clinically supported strains, multi-strain blends, and added functional ingredients such as prebiotics or vitamins to improve efficacy. This shift toward user-friendly, evidence-based, and lifestyle-oriented products, strengthens consumer trust and encourages sustained use, especially among younger and health-conscious demographics.
Consumer Insights
In the U.S., consumers are increasingly turning to probiotic dietary supplements as part of a proactive approach to digestive and immune health. According to the NCCIH, probiotics are among the most commonly used dietary supplements by American adults. Many consumers consume probiotics daily to maintain gut balance, reduce bloating, or support immunity, reflecting a shift toward preventive wellness rather than reactive treatment. In August 2023, Circana reported that probiotics represented about 9% of U.S. vitamin sales, supported by growing consumer focus on gut health and wellness. The report highlighted category growth, retail channels, emerging formats, and opportunities across women’s and men’s health. The growing popularity of personalized nutrition and clean-label supplements also influences purchasing decisions, as users increasingly seek transparent ingredient lists and clinically validated strains. The evolving health awareness, combined with easy retail availability across pharmacies and online platforms, continues to drive consistent product adoption across varied demographic groups in the U.S.
To learn more about this report,Download Free Sample Report
The U.S. probiotic dietary supplement market attracts consumers across a diverse range of age and gender groups. Adult consumers form the core segment, motivated by digestive wellness, immune support, and overall preventive health. Women often represent a slightly larger share of users, reflecting a higher propensity for dietary supplement adoption and health-conscious behaviors. Younger adults show growing interest in convenient formats such as gummies and powders. Middle-aged and older adults focus on clinically supported formulations that promote long-term gut and immune health. Parents are increasingly giving probiotics to children and infants to support early digestive and immune development. The market spans all life stages, encompassing individuals seeking general wellness, targeted health benefits, and functional nutrition solutions.
Market Dynamics
The growing consumer focus on digestive wellness is creating sustained demand for probiotic dietary supplements in the U.S. Consumers are increasingly incorporating functional nutrition products into their daily routines to support digestive regularity, intestinal balance, and overall nutritional well-being. This trend is particularly relevant as consumers seek convenient alternatives to traditional approaches for maintaining digestive health and managing everyday gastrointestinal discomfort.
In addition, the increasing adoption of functional foods and beverages is strengthening consumer familiarity with probiotics and their role in wellness-oriented nutrition. Consumers are also becoming more attentive to the connection between digestive health and broader aspects of well-being, encouraging demand for products positioned around microbiome support and daily nutritional maintenance. The availability of probiotics through pharmacies, specialty health stores, supermarkets, and direct-to-consumer channels is further integrating these products into routine health and wellness purchases.
Variations in the effectiveness of probiotic strains and challenges associated with maintaining product stability can limit the broader adoption of probiotic dietary supplements in the U.S. Probiotic benefits can vary considerably depending on the strain, formulation, dosage, storage conditions, and intended use. This variability can make it difficult for consumers to assess products based solely on broad probiotic claims and may create uncertainty regarding the expected benefits of individual formulations.
Furthermore, maintaining the viability and potency of live microorganisms throughout manufacturing, transportation, storage, and the product's shelf life presents technical challenges for manufacturers. Exposure to temperature, moisture, oxygen, and other environmental conditions can affect probiotic stability. Manufacturers may therefore require specialized processing, packaging, and storage solutions to preserve product quality. These requirements can increase production and distribution costs while creating additional challenges for brands seeking to maintain consistent product performance across retail and distribution networks.
Growing interest in the human microbiome is creating opportunities for manufacturers to develop more advanced probiotic dietary supplements. Research into the relationship between specific microorganisms and different aspects of human health is encouraging companies to move beyond conventional formulations and explore strain-specific products designed for more targeted consumer needs. This development can support differentiated products focused on areas such as digestive comfort, women's wellness, healthy aging, metabolic wellness, and immune support.
Advances in microbiome research, fermentation technologies, delivery systems, and formulation techniques are also enabling manufacturers to improve the stability and functionality of probiotic products. Companies can further differentiate their offerings through synbiotic formulations that combine probiotics with prebiotics, postbiotic ingredients, and other functional components. Growing consumer interest in transparent ingredient sourcing, clinically studied strains, and science-backed formulations also creates opportunities for brands to communicate product differentiation more effectively. These developments can support premium product positioning and encourage manufacturers to expand specialized probiotic portfolios in the U.S. market.
Analyst Perspective
The U.S. probiotic dietary supplement market is expanding as rising consumer awareness of gut health, immunity, and microbiome wellness drives demand beyond basic digestive support into specialized areas like women’s health. Broad availability across pharmacies, e-commerce, and direct-to-consumer channels continues to boost adoption. To succeed in this increasingly crowded space, brands must build competitive moats around strain-specific clinical evidence, product stability, transparent labeling, and proven potency. Consumers are becoming more discerning, favoring scientifically validated formulas with targeted health claims over generic options. Long-term market leaders will be those that pair clinical research with personalized nutrition trends and novel, convenient delivery formats. Ultimately, combining strong science, clear positioning, and robust omnichannel distribution remains the key to capturing high-value market share.
Form Insights
The tablets & softgels segment held the largest market revenue share of 38.0% in 2025. The probiotics dietary supplements segment, encompassing tablets and softgels, appeals to consumers seeking convenient, reliable, and scientifically validated probiotic intake. Tablets are preferred by those who favor a solid, often smaller, and easily portable dosage form, offering precise probiotic titration. In contrast, softgels stand out due to their enhanced bioavailability and encapsulated liquid or semi-solid probiotic formulations, which cater to individuals looking for easy swallowing and rapid digestion. Both tablets and softgels benefit from advanced encapsulation technologies that improve the viability of probiotic strains and ensure their targeted delivery to the gut.
To learn more about this report,Download Free Sample Report
The chewables & gummies segment is expected to grow at a CAGR of 6.3% over the forecast period from 2026 to 2033. One of the primary drivers is the increasing consumer preference for convenient and palatable alternatives to traditional pill-based supplements. Gummy supplements offer a tasty and easy-to-consume format, making them particularly appealing to children and adults who may find swallowing pills challenging. This shift towards more enjoyable supplement formats aligns with the broader trend of consumers seeking functional foods that support overall wellness. The chewable and gummy formats also align well with increasing health awareness and lifestyle trends demanding functional yet enjoyable health products.
Application Insights
The gastrointestinal health segment dominated the market with a revenue share of 64.2% in 2025. The dominance of this segment is primarily driven by the increasing prevalence of digestive disorders and a growing consumer focus on gut health. Conditions such as antibiotic-associated diarrhea, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) have increased awareness about the significance of maintaining a healthy gut microbiome. Probiotics are well-regarded for maintaining a balance of gut bacteria, improving digestion, and enhancing overall gastrointestinal function. This growing recognition has led to a significant rise in consumer interest in probiotic supplements focused on gut health, shaping the industry's product development and marketing strategies. Consequently, gastrointestinal health remains a key factor driving growth and innovation in the U.S. market.
To learn more about this report,Download Free Sample Report
The immunity segment is expected to grow at the fastest CAGR of 5.8% over the forecast period from 2026 to 2033. The segment's rapid growth is primarily driven by increasing consumer awareness of the critical role of gut health in overall immune function. Probiotics, particularly strains such as Lactobacillus rhamnosus and Bifidobacterium lactis, are recognized for their potential to enhance the body's natural defenses by promoting a balanced gut microbiome. The health landscape has further strengthened this awareness, leading to a surge in demand for supplements that support immune health.
End Use Insights
The adults segment accounted for the largest revenue share of 55.7% in 2025. Lifestyle-focused health management and the desire for convenient daily wellness solutions are key factors contributing to the growth of this segment. Adults increasingly seek supplements to support digestive balance, immune function, and overall vitality amid busy routines and dietary gaps. The availability of distinct product formats, such as tablets, softgels, gummies, and powders, allows consumers to choose options that fit their preferences and schedules, encouraging consistent use. This combination of convenience, targeted benefits, and lifestyle alignment has positioned adults as the fastest-growing consumer group in the market.
To learn more about this report,Download Free Sample Report
The infants segment is projected to grow at the fastest CAGR of 9.3% over the forecast period from 2026 to 2033, driven by increasing parental focus on early-life digestive health and immune system support. Caregivers seek probiotics that can promote healthy gut microbiota, alleviate colic, and reduce the risk of gastrointestinal discomfort in infants. Products designed for this age group, such as liquid drops and powders, offer easy administration and age-appropriate dosing, ensuring safety and convenience for parents.
Key U.S. Probiotic Dietary Supplement Company Insights
Some key companies in the U.S. probiotic dietary supplement market include Vitakem Nutraceutical Inc., BIOHMHealth, and NOW Foods.
To learn more about this report,Download Free Sample Report
- Vitakem Nutraceutical, Inc., specializes in custom nutraceutical solutions. The company offers powders, capsules, tablets, gummies, softgels, and more, tailored to consumers' needs.
Key U.S. Probiotic Dietary Supplement Companies
-
Vitakem Nutraceutical Inc.
-
dsm-firmenich
-
BIOHMHealth
-
Novonesis Group
-
NOW Foods
-
ProbioFerm
-
Amway
-
Abbott
-
Nestle Health Science
-
Glanbia PLC
-
BioGaia
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (dsm-firmenich, Novonesis Group, NOW Foods, Amway, Abbott, Nestlé Health Science, Glanbia PLC)
Expand probiotic portfolios across digestive, immune, microbiome, and specialized nutrition applications. Invest in clinically supported strains, formulation innovation, quality control, omnichannel distribution, practitioner engagement, and science-led product development.
Strong brand recognition, established distribution and formulation capabilities, broad nutrition portfolios, and access to scientific and clinical expertise. Diverse product and ingredient capabilities support participation across multiple probiotic applications.
Higher R&D, clinical validation, quality-control, and regulatory costs. Broad portfolios can make individual probiotic products harder to differentiate in a crowded and increasingly specialized market.
Emerging / Specialized Players (BIOHM Health, ProbioFerm, BioGaia)
Focus on targeted gut-health needs through specialized probiotic formulations, clinically researched strains, microbiome-focused solutions, and convenient delivery formats. Leverage digital engagement, direct-to-consumer channels, and specialized positioning to build consumer awareness. BIOHM also combines probiotics with microbiome testing and personalized recommendations.
Greater agility in developing targeted microbiome and digestive-health solutions. Strong differentiation through specialized strains, clinically tested formulations, and focused gut-health positioning. BioGaia, for example, offers products across gut, immune, and oral health and multiple delivery formats.
Comparatively narrower portfolios and distribution reach than diversified nutrition companies. Greater dependence on specialized probiotic categories and consumer education can increase customer-acquisition and differentiation challenges.
Recent Developments:
-
In October 2025, Lemme introduced Lemme Purr Lollipops and announced that it was launching its innovative Lemme Purr Probiotic Lollipops, exclusively at Target on October 26th, building on its status as the top vaginal probiotic gummy brand. The lollipops include the SNZ 1969 probiotic strain, real pineapple extract, and vitamin C, which turns feminine self-care into a delicious daily ritual.
-
In October 2024, ADM introduced a platform offering over 25 market-ready food and supplement concepts tailored for users of GLP-1 and other anti-obesity medications (AOMs).
U.S. Probiotic Dietary Supplement Market Report Scope
Report Attribute
Details
Market size in 2025
USD 2.7 billion
Estimated market size in 2026
USD 2.8 billion
Projected market size by 2033
USD 4.0 billion
Growth rate (Revenue)
CAGR of 4.8% from 2026 to 2033
Actuals
2021 - 2025
Forecast period
2026 - 2033
Quantitative (Revenue) units
Revenue in USD billion/million, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Form, application, and end use
Country scope
U.S.
Key companies profiled
Vitakem Nutraceutical Inc.; dsm-firmenich; BIOHMHealth; Novonesis Group; NOW Foods; ProbioFerm; Amway; Abbott; Nestle Health Science; Glanbia PLC; BioGaia
Customization scope
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
U.S. Probiotic Dietary Supplement Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. probiotic dietary supplement market report on the basis of form, application, and end use.
-
Form Outlook (Revenue, USD Million, 2021 - 2033)
-
Chewable & Gummies
-
Capsules
-
Powders
-
Tablets & Softgels
-
Others
-
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Sports Fitness
-
Energy & Weight Management
-
General Health
-
Bone & Joint Health
-
Gastrointestinal Health
-
Immunity
-
Cardiac Health
-
Diabetes
-
Anti-cancer
-
Skin/Hair/Nails
-
Brain/Mental Health
-
Others (Insomnia, Anti-aging, Menopause)
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Infants
-
Children
-
Adults
-
Geriatric
-
Research Methodology
The U.S. probiotic dietary supplement market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing—reconciling supply-side and demand-side estimates—and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each U.S. probiotic dietary supplement segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Application
Revenue capture definition
Sports Fitness
This segment includes the sales of supplements supporting physical performance, muscle growth, and exercise recovery.
Energy & Weight Management
This segment includes the sales of supplements supporting energy levels, metabolism, and weight management.
General Health
This segment includes the sales of supplements supporting overall health, wellness, and nutritional needs.
Bone & Joint Health
This segment includes the sales of supplements supporting bone strength, joint health, and mobility.
Gastrointestinal Health
This segment includes the sales of supplements supporting digestion, gut health, and intestinal balance.
Immunity
This segment includes the sales of supplements supporting immune function and the body’s natural defenses.
Cardiac Health
This segment includes the sales of supplements supporting heart health and cardiovascular function.
Diabetes
This segment includes the sales of supplements supporting blood sugar control and metabolic health.
Anti-cancer
This segment includes the sales of supplements marketed to support cellular health and antioxidant protection.
Skin/Hair/Nails
This segment includes the sales of supplements supporting skin, hair, and nail health.
Brain/Mental Health
This segment includes the sales of supplements supporting cognitive function, memory, focus, and mental wellness.
Others (insomnia, anti-aging, menopause)
This segment includes the sales of supplements supporting sleep, healthy aging, and menopause wellness.
Estimation Model
Layer No.
Layer Name
Key Question
Description
01
Target Population Layer
Who has a relevant gut-health or wellness need?
Identify the U.S. adult and child population and apply relevant health and wellness need rates across key probiotic-related areas, including digestive health, gut microbiome balance, immune support, bowel regularity, antibiotic-associated digestive concerns, and overall preventive wellness, to define the addressable consumer population. Probiotic use is commonly associated with digestive and general health objectives.
02
Supplement Adoption Layer
Who uses dietary supplements?
Apply dietary supplement usage and probiotic adoption rates to the eligible U.S. population. This layer filters the broader health-conscious population to consumers who actively use supplements for digestive health, immunity, general wellness, or other targeted health benefits. Consumer research indicates substantial awareness and active interest in probiotics, supporting their position within the broader dietary supplement category.
03
Men's Health Conversion Layer
Who actively purchases probiotic dietary supplements?
Apply a probiotic-specific participation and conversion rate to supplement users, filtering for consumers who purchase probiotic dietary supplements rather than obtaining probiotics primarily through foods and beverages. Include consumers purchasing products positioned around digestive health, gut microbiome support, immune health, bowel function, general wellness, and targeted nutritional needs.
04
Monetisation Layer
How much revenue is generated?
Multiply estimated paying probiotic dietary supplement users by blended annual consumer spending per user, incorporating differences in product form, formulation, potency, pack size, purchase frequency, premium or clinically positioned products, subscription models, and online/offline purchasing. Add incremental B2B, practitioner, or institutional revenue where applicable to arrive at the addressable market revenue.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Gut Health, Digestive Wellness & Probiotic Supplement Trends
Conducted a focused analysis of probiotic supplements covering digestive health, immune support, microbiome balance, bowel regularity, general wellness, and targeted nutritional needs. The assessment also considered evolving consumer preferences, probiotic strains, dosage formats, formulation trends, and demand for science-backed gut-health solutions.
Helps stakeholders identify high-growth probiotic applications, understand changing consumer priorities, and evaluate product innovation and commercialization opportunities across the U.S. probiotic supplement market.
Preventive Health & Probiotic Adoption Trends
Evaluated probiotic adoption across key consumer needs, including gastrointestinal health, immunity, general wellness, and preventive nutrition. The analysis assessed growing awareness of gut health, interest in daily supplementation, convenient dosage formats, and expanding access through pharmacies, specialty retailers, e-commerce, and direct-to-consumer channels.
Provides insights into emerging consumer needs, high-potential applications, preferred product formats, and commercially relevant probiotic segments to support product positioning, portfolio expansion, and targeted marketing strategies.
Strain Innovation & Specialized Probiotic Opportunity Assessment
Assessed demand for targeted probiotic solutions, including strain-specific formulations, digestive health products, immune-support products, women’s and children’s probiotics, and convenient formats such as gummies, capsules, powders, and softgels. The assessment also considered clinical substantiation, formulation differentiation, product quality, stability, and consumer trust.
Supports investment and expansion strategies by identifying specialized application areas, evaluating product differentiation opportunities, and highlighting innovation pathways across targeted probiotic supplementation.
Frequently Asked Questions About This Report
The U.S. probiotic dietary supplement market size was valued at USD 2.7 billion in 2025 and is estimated at USD 2.8 billion for 2026.
Some key players operating in the U.S. probiotic dietary supplements market include dsm-firmenich; BIOHMHealth; Novonesis Group; NOW Foods; ProbioFerm; Amway; Abbott; Nestle Health Science; Glanbia PLC; and BioGaia.
The increasing awareness of gut health, fueled by rising digestive and immune health concerns, drives market growth.
The gastrointestinal health segment dominated the market with a revenue share of 64.2% in 2025, while the immunity segment is expected to grow at the fastest CAGR of 5.8% over the forecast period from 2026 to 2033.
The adult segment accounted for the largest revenue share of 55.7% in 2025, and the infants segment is projected to grow at the fastest CAGR of 9.3% over the forecast period from 2026 to 2033.
The tablets & softgels segment held the largest market revenue share of 38.0% in 2025. The probiotics dietary supplements segment, encompassing tablets and softgels, appeals to consumers seeking convenient, reliable, and scientifically validated probiotic intake.
The U.S. probiotic dietary supplements market is expected to grow at a compounded annual growth rate of 4.8% from 2026 to 2033 to reach USD 4.0 billion by 2033.
About the Author(s)
Nutraceuticals & Functional Foods Research Team
Consumer Goods · Nutraceuticals & Functional FoodsThis report was authored by the nutraceuticals & functional foods research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the nutraceuticals & functional foods segment of the consumer goods industry. All findings are based on proprietary consumer goods databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.